VerifyRecall
Alerts
RECALL RECORD — CLASS IIRecall closedF-2946-2015/FDA enforcement
Novacare, LLC·Food·May 27, 2015

Glucosamine 750 mg 120 Ct, Capsule, Dosage: 12 Capsules, 750 mg Ea., Three Times Daily With…

What you need to know

Class II

  • What happened

    TSN Labs is conducting a field action on Glucosamine 750 mg 120 ct due to inadequate allergen labeling.

  • Health risk

    The product may cause temporary or medically reversible health consequences, or the probability of serious harm is remote. A safety issue that does not fit the standard pathogen, allergen, chemical or quality categories.

  • Action required

    Check the identifying codes below and stop using the product. Return it to the retailer for a refund or dispose of it safely, following the recall notice.

Recall closed · classified by the FDANationwide (US)More food

Advertisement

Ad

Know someone who bought this?

A quick share can keep a pantry check from becoming a missed warning.

Share via WhatsApp

Match before you discard

Product identification

Source: FDA FOOD

Brand nameNovacare, LLC
Recalling firmNovacare, LLCMurray, UT, United States
UPC / barcodesNo UPC listed in the FDA enforcement record.
Lot / date codes
  • Lot #s: 4102801, 2071918.2, 2061401, 2032006
Distribution area
Nationwide

Nationwide. No foreign or VA/govt/military consignees.

United States

Quantity affected961 bottles.
Recall initiationFDA report date: August 19, 2015
FDA recall numberF-2946-2015

Beyond the headline

The recall, in context

Novacare, LLC initiated this food recall on May 27, 2015. The FDA enforcement report states: TSN Labs is conducting a field action on Glucosamine 750 mg 120 ct due to inadequate allergen labeling. The FDA report lists distribution as: Nationwide. No foreign or VA/govt/military consignees.

The FDA enforcement report describes the reason as: TSN Labs is conducting a field action on Glucosamine 750 mg 120 ct due to inadequate allergen labeling.

Glucosamine 750 mg 120 Ct, Capsule, Dosage: 12 Capsules, 750 mg Ea., Three Times Daily With… was made or distributed by Novacare, LLC in Murray, UT, United States. This page reflects FDA report F-2946-2015, dated August 19, 2015.

Why this is a Class II recall

Class II means the product may cause temporary or medically reversible health consequences, or the probability of serious harm is remote. In this recall, a safety issue that does not fit the standard pathogen, allergen, chemical or quality categories.

FDA definition

The product may cause temporary or medically reversible health consequences, or the probability of serious harm is remote.

What to do now

  1. 1

    Stop using it

    Do not eat, drink or take the affected product.

  2. 2

    Check the codes

    Compare the lot and date codes against the table above.

  3. 3

    Return or discard

    Contact the retailer or recalling firm about a refund, and dispose of the product safely.

Consumer safety guide

Undeclared allergen

Symptoms to watch for

Hives, swelling, wheezing, coughing, vomiting, abdominal pain or a drop in blood pressure. Anaphylaxis is a medical emergency.

When symptoms may appear

Allergic reactions often begin within minutes to a few hours of eating the allergen.

Higher-risk groups

Anyone with a diagnosed food allergy, especially children, and people with a history of anaphylaxis or asthma.

What to do now

  1. 1Do not eat or serve the affected product if you or anyone in the household has a diagnosed allergy.
  2. 2If symptoms such as swelling, wheezing or breathing difficulty occur, use the person's prescribed emergency plan and call emergency services.
  3. 3Keep the packaging, contact the retailer or manufacturer for a refund, and read the official recall notice for the exact allergen.

For a severe allergic reaction, do not wait for a callback or refund process before seeking emergency care.

This is general consumer safety information, not medical advice or a diagnosis. Follow the official recall notice and contact a healthcare professional if you have concerns about exposure or symptoms.

Frequently asked

Questions about this recall

What is the Glucosamine 750 mg 120 Ct, Capsule, Dosage: 12 Capsules, 750 mg Ea., Three Times Daily With… recall?

Novacare, LLC recalled Glucosamine 750 mg 120 Ct, Capsule, Dosage: 12 Capsules, 750 mg Ea., Three Times Daily With… in an FDA Class II enforcement action reported as F-2946-2015. TSN Labs is conducting a field action on Glucosamine 750 mg 120 ct due to inadequate allergen labeling.

What should I do if I bought this product?

Check the identifying codes below and stop using the product. Return it to the retailer for a refund or dispose of it safely, following the recall notice. Do not eat or serve the affected product if you or anyone in the household has a diagnosed allergy. If symptoms such as swelling, wheezing or breathing difficulty occur, use the person's prescribed emergency plan and call emergency services. Keep the packaging, contact the retailer or manufacturer for a refund, and read the official recall notice for the exact allergen.

Is the Novacare, LLC recall still active?

The FDA lists this recall as recall closed. It remains relevant if you still have the affected product or need to identify a historical recall.

Where can I verify this recall?

This page is normalized from the openFDA enforcement record F-2946-2015. You can verify it directly using the official source link on this page. VerifyRecall updates its index from public FDA enforcement data and does not replace advice from the FDA, the recalling firm or a healthcare professional.

Verify before you act.

VerifyRecall is independent and not affiliated with the FDA. Always confirm the latest status on the official source record.

Official source

Related alerts

Recent Other safety concern recalls

All alerts
Class II·

Sempio Food Services, INC

Sempio Yellow Peach

Elevated level of lead in canned peaches

INFood
Class II·

Stewart's Shops Corp.

Stewarts Shops Vanilla Heavenly Medley 1/2 Gallon (1.89 L)

Foreign object: May contain pieces of metal

NY, VT, NHFood

Record last synced from official openFDA enforcement data on November 14, 2026. Source record: official FDA notice.